SARS-CoV-2 vaccination and COVID-19 infections in people with multiple sclerosis treated with ocrelizumab in the prospective, multicenter, noninterventional MuSicalE and CONFIDENCE studies

M Trojano; S Meuth; M Buttmann; MS Weber; Pesch V Van; R Alroughani; A Rovira; G Cutter; J Hobart; M Sierzega; Q Wang; L Craveiro; D Dzhenkova; J Eggebrecht; EM-L Rouzic; T Ziemssen

doi:10.1177/13524585221123687

SARS-CoV-2 vaccination and COVID-19 infections in people with multiple sclerosis treated with ocrelizumab in the prospective, multicenter, noninterventional MuSicalE and CONFIDENCE studies

M Trojano, S Meuth, M Buttmann, MS Weber, Pesch V Van, R Alroughani, A Rovira, G Cutter, J Hobart, M Sierzega, Q Wang, L Craveiro, D Dzhenkova, J Eggebrecht, EM-L Rouzic, T Ziemssen

Peninsula Medical School

Research output: Contribution to conference › Conference paper (not formally published) › peer-review

Original language	English
DOIs	https://doi.org/10.1177/13524585221123687
Publication status	Published - Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/13524585221123687

Cite this

Trojano, M., Meuth, S., Buttmann, M., Weber, MS., Van, P. V., Alroughani, R., Rovira, A., Cutter, G., Hobart, J., Sierzega, M., Wang, Q., Craveiro, L., Dzhenkova, D., Eggebrecht, J., Rouzic, EM.-L., & Ziemssen, T. (2022). SARS-CoV-2 vaccination and COVID-19 infections in people with multiple sclerosis treated with ocrelizumab in the prospective, multicenter, noninterventional MuSicalE and CONFIDENCE studies. https://doi.org/10.1177/13524585221123687

@conference{c9e9fd5729a74e12a248a405c5df6df9,

title = "SARS-CoV-2 vaccination and COVID-19 infections in people with multiple sclerosis treated with ocrelizumab in the prospective, multicenter, noninterventional MuSicalE and CONFIDENCE studies",

author = "M Trojano and S Meuth and M Buttmann and MS Weber and Van, {Pesch V} and R Alroughani and A Rovira and G Cutter and J Hobart and M Sierzega and Q Wang and L Craveiro and D Dzhenkova and J Eggebrecht and EM-L Rouzic and T Ziemssen",

year = "2022",

month = oct,

doi = "10.1177/13524585221123687",

language = "English",

}

Trojano, M, Meuth, S, Buttmann, M, Weber, MS, Van, PV, Alroughani, R, Rovira, A, Cutter, G, Hobart, J, Sierzega, M, Wang, Q, Craveiro, L, Dzhenkova, D, Eggebrecht, J, Rouzic, EM-L & Ziemssen, T 2022, 'SARS-CoV-2 vaccination and COVID-19 infections in people with multiple sclerosis treated with ocrelizumab in the prospective, multicenter, noninterventional MuSicalE and CONFIDENCE studies'. https://doi.org/10.1177/13524585221123687

TY - CONF

T1 - SARS-CoV-2 vaccination and COVID-19 infections in people with multiple sclerosis treated with ocrelizumab in the prospective, multicenter, noninterventional MuSicalE and CONFIDENCE studies

AU - Trojano, M

AU - Meuth, S

AU - Buttmann, M

AU - Weber, MS

AU - Van, Pesch V

AU - Alroughani, R

AU - Rovira, A

AU - Cutter, G

AU - Hobart, J

AU - Sierzega, M

AU - Wang, Q

AU - Craveiro, L

AU - Dzhenkova, D

AU - Eggebrecht, J

AU - Rouzic, EM-L

AU - Ziemssen, T

PY - 2022/10

Y1 - 2022/10

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000866540802154&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008

U2 - 10.1177/13524585221123687

DO - 10.1177/13524585221123687

M3 - Conference paper (not formally published)

ER -

SARS-CoV-2 vaccination and COVID-19 infections in people with multiple sclerosis treated with ocrelizumab in the prospective, multicenter, noninterventional MuSicalE and CONFIDENCE studies

UN SDGs

Access to Document

Other files and links

Cite this